Stockscreener 앱 받기
96.70
0.76%
-0.74
전일 마감가:
$97.44
열려 있는:
$98.26
하루 거래량:
726.94K
Relative Volume:
0.72
시가총액:
$3.77B
수익:
$117.67M
순이익/손실:
$-1.88B
주가수익비율:
-1.5974
EPS:
-60.5369
순현금흐름:
$-621.36M
1주 성능:
-3.40%
1개월 성능:
+11.12%
6개월 성능:
+164.14%
1년 성능:
+455.59%
1일 변동 폭
$95.13
$100.69
1주일 범위
$94.83
$108.93
52주 변동 폭
$17.12
$115.76
Grail Inc Stock (GRAL) Company Profile
명칭
Grail Inc
전화
(833) 694-2553
주소
1525 O'BRIEN DRIVE, MENLO PARK
GRAL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GRAL
Grail Inc
|
96.70 | 3.80B | 117.67M | -1.88B | -621.36M | -60.54 |
|
TMO
Thermo Fisher Scientific Inc
|
618.72 | 234.69B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
235.99 | 169.45B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
715.37 | 56.86B | 4.17B | 1.03B | 940.22M | 12.61 |
|
IQV
Iqvia Holdings Inc
|
237.68 | 41.09B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
A
Agilent Technologies Inc
|
139.64 | 41.06B | 6.95B | 1.30B | 1.15B | 4.5696 |
Grail Inc Stock (GRAL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 재개 | Morgan Stanley | Equal-Weight |
| 2025-11-12 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2025-04-21 | 개시 | Canaccord Genuity | Buy |
| 2024-11-27 | 개시 | Morgan Stanley | Equal-Weight |
| 2024-11-15 | 개시 | Wolfe Research | Peer Perform |
| 2024-10-17 | 개시 | Guggenheim | Neutral |
모두보기
Grail Inc 주식(GRAL)의 최신 뉴스
Understanding Momentum Shifts in (GRAL) - Stock Traders Daily
Lobbying Update: $60,000 of GRAIL INC. lobbying was just disclosed - Quiver Quantitative
GRAIL (NASDAQ:GRAL) Trading Down 5.7%Time to Sell? - MarketBeat
GRAIL Inc (GRAL) Shares Gap Down to $99.95 on Jan 15 - GuruFocus
GRAIL (GRAL) Price Target Increased by 46.34% to 91.80 - MSN
Market Fear: Is GRAIL LLC likely to announce a buybackM&A Rumor & High Win Rate Trade Alerts - baoquankhu1.vn
Canaccord Genuity reiterates Buy rating on GRAIL stock after strong results - Investing.com Nigeria
Does Morgan Stanley’s Hold on GRAIL (GRAL) Reframe Expectations for Galleri’s Path to Profitability? - simplywall.st
Illumina Produces Midteens Earnings Growth in 2025, Distancing Itself From the Grail Debacle - morningstar.com
GRAIL Surges as Canaccord Genuity Sets Ambitious $105 Price Target Following Robust 2025 Growth - FinancialContent
GRAIL Reaches Analyst Target Price - Nasdaq
Commonwealth Equity Services LLC Sells 37,220 Shares of GRAIL, Inc. $GRAL - MarketBeat
GRAIL, Inc. (GRAL) Stock Analysis: Navigating the Healthcare Frontier with Strong Revenue Growth - DirectorsTalk Interviews
Grail rises as 2025 revenue guidance above consensus - MSN
Why GRAIL Inc Stock Is Suddenly Surging Higher - TipRanks
Samsung and GRAIL Announce Strategic Collaboration To Bring GRAIL’s Galleri® Multi-Cancer Early Detection Test to Asia - Samsung Global Newsroom
Can GRAIL Inc. (NL0) stock reach $200 price targetTrade Risk Assessment & Community Verified Trade Alerts - Улправда
GRAIL, Inc. $GRAL Shares Sold by Cwm LLC - MarketBeat
Morgan Stanley eyes emerging growth for Grail (GRAL) as sector valuations reach equilibrium - MSN
GRAIL (GRAL) Is Up 12.3% After Samsung-Backed Asian Galleri Deal And Trial DataHas The Bull Case Changed? - Sahm
GRAIL, Inc. (GRAL) Stock Analysis: Eyeing a 9.66% Upside with Innovative Cancer Detection - DirectorsTalk Interviews
Why Illumina (ILMN) Is Up 6.5% After Advancing Grail Divestiture Plan And What's Next - Yahoo Finance
Avoiding Lag: Real-Time Signals in (GRAL) Movement - Stock Traders Daily
Should Illumina’s (ILMN) Grail Spinoff to Ease Regulatory Pressure Require Action From Investors? - simplywall.st
Assessing GRAIL (GRAL) Valuation After Pathfinder 2 Success and Samsung’s Asian Galleri Deal - simplywall.st
Small-Cap Standouts: These 3 Stocks Rose Over 300% in 2025 - Finviz
Grail Inc (GRAL) Climbs 380% on Strong Optimism for Cancer Detection Kit - Insider Monkey
GRAIL Earnings Notes - Trefis
GRAIL stock drops in New York session as Galleri FDA filing timeline returns to focus - ts2.tech
Legal Advantage Investments Inc. Invests $1.24 Million in GRAIL, Inc. $GRAL - MarketBeat
Early Cancer Detection Firm Grail Leads Nasdaq Gainers as Stock Jumps 20% - MSN
Morgan Stanley Eyes Emerging Growth for Grail (GRAL) as Sector Valuations Reach Equilibrium - Insider Monkey
GRAIL: Making Strides In Cancer Detection (NASDAQ:GRAL) - Seeking Alpha
Carnegie Investment Counsel Increases Stake in GRAIL, Inc. $GRAL - MarketBeat
Blood test finds seven times more cancers than standard screenings - OHSU News
(GRAL) Risk Channels and Responsive Allocation - Stock Traders Daily
Archaeopteryx | The Holy Grail of Fossils at the Field Museum - Britannica
Sheets Smith Investment Management Takes $1.69 Million Position in GRAIL, Inc. $GRAL - MarketBeat
GRAL Stock: Cancer Detection Firm Targets Further Upside After 381% Rally - CMC Markets
Why Fusion Is Considered Energy’s Elusive Holy Grail - The Wall Street Journal
Westwood Holdings Group Inc. Has $899,000 Holdings in GRAIL, Inc. $GRAL - MarketBeat
How Recent Catalysts Are Shifting the Narrative for GRAIL - Yahoo Finance
GRAIL to Present at the 44th Annual J.P. Morgan Healthcare Conference - The AI Journal
NWF Advisory Services Inc. Makes New $1.06 Million Investment in GRAIL, Inc. $GRAL - MarketBeat
64,560 Shares in GRAIL, Inc. $GRAL Bought by Caxton Associates LLP - MarketBeat
Trading the Move, Not the Narrative: (GRAL) Edition - news.stocktradersdaily.com
Here's Why Grail Soared, Again, in November - AOL.com
BBR Partners LLC Sells 35,000 Shares of GRAIL, Inc. $GRAL - MarketBeat
GRAIL (GRAL) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
GRAIL : Non-Invasive Urinary Detection of Upper Tract Urothelial Carcinoma via Methylation Patterns in Cell-Free DNA View Presentation - marketscreener.com
Rhumbline Advisers Has $2.54 Million Holdings in GRAIL, Inc. $GRAL - MarketBeat
Grail Inc (GRAL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Grail Inc 주식 (GRAL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| RAGUSA ROBERT P | Chief Executive Officer |
Dec 03 '25 |
Sale |
95.24 |
40,000 |
3,809,535 |
688,029 |
| Freidin Aaron | Chief Financial Officer |
Dec 03 '25 |
Sale |
99.15 |
25,000 |
2,478,818 |
259,077 |
2.51%
0.74%
자본화:
|
볼륨(24시간):